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Background: In Cameroon, the use of edible plants is an integral part of dietary behavior. However, evidence of
the antimicrobial as well as the cytotoxic effects of many of them has not been investigated. In the present study,
aqueous and methanol extracts from barks, seeds, leaves and roots of three Cameroonian edible plants namely
Garcina lucida, Fagara heitzii and Hymenocardia lyrata were evaluated for their cytotoxic and antimicrobial activities.
Methods: Antibacterial and antifungal activities were assessed by the broth micro-dilution method meanwhile the
cytotoxicity was performed using sulphorhodamine B assay (SRB) against the human leukemia THP-1, the alveolar
epithelial A549, prostate cancer PC-3, breast adenocarcinoma MCF-7 and cervical cancer HeLa cell lines.
Results: The minimum inhibitory concentration (MIC) values of the seven tested extracts ranged from 62.5 μg/ml
to 1000 μg/ml. The methanol (MeOH) extract from the roots of H. lyrata showed the highest antibacterial activity
against Gram-positive bacteria S. aureus and S. epidermitis. The best antifungal activity was obtained with the MeOH
extract from the leaves of G. lucida against C. tropicalis (MIC value of 62.5 μg/ml). The in vitro antiproliferative activity
revealed that, extract from the bark of F. heitzii and extract from H. lyrata roots had significant cytotoxic activity on
THP-1 (IC50 8.4 μg/ml) and PC-3 (IC50 9.5 μg/ml) respectively.
Conclusion: Our findings suggest that Cameroonian spices herein studied could be potentially useful for the
development of therapeutic agents against bacterial infections as well as for prostate and leukemia cancer.
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Plants have served humans well as valuable components
of seasonings as well as medicines, and have played a
significant role in maintaining human health and im-
proving the quality of human life for thousands of years.
There is no doubt that increasing our intake of spices is
one of the most effective, convenient and economical
ways in which we can fortify ourselves against infectious
diseases and related cancers [1]. In the area of cancer
prevention, plants consumption such as spices and their
constituents as potential chemopreventive agents re-
mains an extensive research topic. Numerous studies
have been published in regards to the relation between* Correspondence: jpdzoyem@yahoo.fr
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reproduction in any medium, provided the orplants consumption, cancer prevention, antimicrobial
effects, and overall protection of human health [2]. In
Cameroon, medicinal plants consumption is an integral
part of dietary behavior, but relatively little is known
about their antimicrobial potential and anti-cancer ef-
fects. The three selected edible plants studied herein,
namely Garcinia lucida Vesque, Fagara heitzii (Guill
and Perr) Engl. and Hymenocardia lyrata Tul are recog-
nized for their medicinal virtues and have been reported
to possess various biological activities. The barks, seeds
and leaves of G. lucida are used to treat gastric infec-
tions, gynecological infections, diarrheas and as anti-
poison [3,4]. It has been reported to have antileishmanial
and anti-trypanosomal properties [5,6]. Seeds and barks
of Fagara heitzii (Guill and Perr) Engl have been used to
treat abdominal pains, asthma, appendicitis and toothache
[7]. H. lyrata is well known in Cameroon, where roots and
barks are used as antiparasitic, against gastric ulcer and inl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of reports about the potential of Cameroonian edible
plants in terms of preventing and treating microbial
diseases and cancer [9,10]. The objective of this study was
to evaluate aqueous and methanol extracts from barks,
seeds, leaves and roots of three Cameroonian plants edible
plants for their anticancer activity on human cancer cell
lines of various tissues including as cervix, leukemia, pros-
tate, lung and breast; as well as their antimicrobial acti-
vities against bacterial and fungal pathogens.
Methods
Plant material and extraction
F. heitzii (Rutaceae), G. lucida (Guttiferae) and H. lyrata
(Euphorbiaceae)were harvested in the East region, Ebolowa
and Batchingou in Cameroon. The plants were identified
at the Cameroon National Herbarium where voucher spec-
imens were deposited under the reference number 1441/
HNC, 53354/HNC and 32301/HNC respectively for F.
heitzi, G. lucida and H. lyrata.
Each collected sample (leaves and barks for G. lucida,
roots and barks of H. lyrata, and fruits and roots for F.
heitzii) was dried at room temperature (28 ± 3°C), pulver-
ized and powdered. Each powder (50 g) was macerated in
500 ml of methanol or water for 72 h at room temperature.
After 72 h, the mixture was filtered using a paper filter
Whatman No. 1. Each filtrate was then concentrated under
vacuum (Rotary evaporator, Heidolph WB 200) to obtain
the crude extract. Each crude extract obtained was then
weighed and stored at 4°C.
Cytotoxic activity assay
Cell lines and treatment
The effect of the extracts and compounds on cell growth
was determined in a panel of human tumor cells includ-
ing lung A549 adenocarcinoma, breast carcinoma MCF-
7, prostate carcinoma PC-3, cervical carcinoma HeLa
and acute monocytic leukemia cell line THP-1, obtained
from National Cancer Institute, USA. THP-1, A-549 and
PC-3 were maintained in RPMI medium while MCF-7
and HeLa were cultured in MEM medium. All media
used were supplemented with 10% fetal bovine serum
(FBS), 100 IU/ml penicillin. The cell lines were maintained
under standard cell culture conditions at 37°C and 5%
CO2 in a humidified environment.
Cytotoxic activity by SRB assay
In vitro cytotoxicity against above mentioned five human
cancer cell lines was determined using sulphorhodamine
B assay (SRB) as described previously [11]. Briefly, cells
were harvested in log phase using trypsin (0.05% trypsin,
0.02% EDTA, in PBS). The cell suspensions were diluted
with appropriate growth medium to obtain the cell den-
sities depending on the cell line: (104 cells/well for HeLa,104 cells/well for A549, 104 cells/well for THP-1, 1,
5×104 cells/well for MCF-7 and 104 cells/well for PC-3).
An aliquot of 100 μl of each suspension were seeded in
96 wells cell culture plates. The cells were incubated at
37°C in an atmosphere of 5% CO2 and 95% relative
humidity in a CO2 incubator. After 24 h incubation, test
materials (100 μl/well) at varying concentrations (1, 10,
30 and 50 or 100 μg/ml) were added to the wells
containing cells. Paclitaxel 0.1, 1 and 10 μM was used as
positive control. Suitable controls with equivalent con-
centration of DMSO were also included. The plates were
further incubated for 48 h in a CO2 incubator after
addition of test material. After incubation cells were
fixed by gently layering trichloroacetic acid (50 μl/well,
50% w/v) on top of the medium in all the wells and in-
cubated at 4°C for 1 h. The plates were washed five times
with distilled water and air-dried. Cell growth was mea-
sured by staining with sulforhodamine B dye (0.4% w/v in
1% acetic acid, 100 μl/well). The unbound dye was washed
3–5 times with 1% acetic acid and plates were air dried.
The adsorbed dye was dissolved in Tris-Buffer (100 μl/well,
0.01 M, pH 10.4) and plates were gently shaken for 10 min
on a mechanical shaker. The optical density (OD) was
recorded using a 96 well plate reader. Growth inhibition
was calculated by subtracting mean OD values of respect-
ive blank from the mean OD value of experimental set.
Percentage growth in presence of test material was calcu-
lated considering the growth in absence of any test mater-
ial as 100% and in turn percentage growth inhibition in
presence of test material was calculated. The viability and
growth in the presence of test material is calculated by fol-
lowing formula.
Growth inhibition %ð Þ ¼ OD test sampleð Þ  OD blankð Þ=

OD controlð Þ  OD blankð Þ  100
IC50 value is the concentration of sample required to
inhibit 50% of the cell proliferation and was calculated
by plotting the percentage survival versus the concentra-
tions, using Microsoft Excel. For all samples, each com-




A total of ten microbial strains were tested obtained from
the American Type Culture Collection for their susceptibi-
lity to extracts and compounds. These strains comprised of
three yeasts: Candida albicans (ATCC 90028), Candida
krusei (ATCC 6258), and Candida tropicalis (ATCC 750);
one filamentous fungi: Aspergillus fumigatus (MTCC 1811);
three Gram-negative bacteria: Pseudomonas aeruginosa
ATCC 27853, Escherichia coli ATCC25292, vancomycin-
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positive bacteria: Staphylococcus aureus ATCC 29213,
methicillin-resistant Staphylococcus aureus (MRSA, ATCC
33591) and Staphylococcus epidermidis (ATCC 12228).
They were maintained on agar slant at 4°C and sub-
cultured on a fresh appropriate agar plates 24 h prior to
any antimicrobial test. The Mueller Hinton Agar (MHA)
and Sabouraud dextrose Agar (SDA) were used for the
activation of bacteria and fungi respectively. The Mueller
Hinton Broth (MHB) and RPMI 1640 were used for the
MIC determinations.
Inoculum preparation
Suspensions of bacteria and yeasts were prepared in
sterile normal saline (0.85%) from 24 h grown on SDA
or MHA at 37°C. The turbidity of the microbial suspen-
sion was adjusted with a densitometer to a McFarland
standard of 0.5 for bacteria and 0.9 for yeast, which are
equivalent to 1–5 × 108 CFU/ml and 1–5 × 107 CFU/ml
respectively.
Inoculum suspensions of Aspergillus species were pre-
pared from fresh, mature (3 to 5 days old) cultures grown
on Sabouraud agar or potato dextrose agar slants. The col-
onies were covered with approximately 5 ml of distilled
containing 5% Tween 20. Then, the suspensions were
made by gently probing the colony with the tip of a Pas-
teur pipette and transferred to a sterile tube; the resulting
suspensions were homogenized for 15 s with a vortex
mixer at 2000 rpm. The suspension was filtered and
collected in a sterile tube. The inoculum size was adjusted
to 1-5 × 106 spores/ml by microscopic enumeration with
a cell-counting hematocytometer. Adjusted suspensions
were checked by plating 0.01 ml of a 1:100 dilution onto
PDA plates to determine the viable number of CFU/ml.
The plates were incubated at 37°C and observed daily






































HELA (Cervix) A549 (Lung) PC-3 (Prostate)
Figure 1 Cytotoxic activity of Extracts and paclitaxel determined by t
mL. Data with different alphabetic letters are significantly different (P < 0.0
extract from Fagara heitzii barks; GLB: Methanol extract from Garcina lucida
extract from Hymenocardia lyrata roots; HLBb: Methanol extract from Hymecounted as soon as possible after the observation of visible
growth.
MIC determination
The MIC was performed by broth microdilution method,
with Mueller Hinton Broth (MHB) for bacteria and RPMI
1640 medium (containing L-glutamine, without sodium
bicarbonate and buffered to pH 7.0 with 0.165 M morpho-
line propanesulfonic acid) for fungi. Stock solutions of ex-
tracts were prepared in 100% dimethylsulfoxide (DMSO;
Sigma) and twofold serial dilutions were prepared in
media in amounts of 100 μl per well in 96-well. The
above-mentioned microbial suspensions were further di-
luted to 1:100 in media, and a 100 μl volume of this di-
luted inoculum was added to each well of the plate,
resulting in a final inoculum of 1.5×106 cfu/ml for bac-
teria, 1.5×104 cfu/ml for A. fumigatus and 1.5×105 cfu/ml
for yeasts. The final concentration of samples ranged from
7.8-1000 μg/ml. The medium without the agents was used
as a growth control and the blank control used contained
only the medium. Ciprofloxacin and Amphotericin B
served as the standard drug controls. The microtiter plates
were incubated at 37°C for 24 h, 48 h and 72 h respect-
ively for bacteria, yeasts and Aspergillus species. The plates
were read visually, and the MIC was defined as the lowest
concentration of the antifungal agents that prevented
visible growth with respect to the growth control.
Statistical analysis
The one-way ANOVA at 95% confidence level was used
for statistical analysis.
Results and discussion
In the present study, we have evaluated the antimicrobial
and antiproliferative activity of MeOH and aqueous ex-

















GLL HLR HLBb Paclitaxel
tracts
THP-1 (Leukemia) MCF-7 (Breast)
he percentage of growth inhibition. Extracts were tested at 100 μg/
5). FHF: Methanol extract from Fagara heitzii fruits; FHB: Methanol
barks; GLL: Methanol extract from Garcina lucida leaves; HLR: Methanol
nocardia lyrata barks.
Table 1 IC50 values of the extracts from three Cameroonian edible plants and paclitaxel against human cancer cell
lines
Extracts Cell lines and IC50 (μg/mL)
HeLa (Cervix) A549 (Lung) PC-3 (Prostate) THP-1 (Leukemia) MCF-7 (Breast)
FHF - - 56 - 26
FHB 66 - 76 8.4 42
GLB - - 61 72 73
GLL - - - 38 82
HLR 99 - 9.5 36 32
HLBa nd nd nd nd nd
HLBb 44 - 68 64.5 -
Paclitaxel 12 1 62 4 3
FHF: Methanol extract from Fagara heitzii fruits; FHB: Methanol extract from Fagara heitzii barks; GLB: Methanol extract from Garcina lucida barks; GLL: Methanol
extract from Garcina lucida leaves; HLR: Methanol extract from Hymenocardia lyrata roots; HLBa: Aqueous extract from Hymenocardia lyrata barks; HLBb: Methanol
extract from Hymenocardia lyrata barks; -: value above 100 μg/mL; nd: not determined.
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extracts was assessed on a panel of five human cancer
cell lines at a single concentration of 100 μg/ml. The five
human cell lines used were representative of tumors
from a five types of human tissue including blood, lung,
breast, prostate and cervix tissues. Result of the growth
inhibition effects are shown in Figure 1. A perusal of this
figure revealed that all the extracts tested induced more
than 50% cell death on at least one of the five cell lines.
The most potent extract identified, the methanol extract
from Fagara heitzii barks (FHB) were found to induce
over 60% cell death in 4 out of 5 cell lines. With the re-
spective highest growth inhibition percentage of 95.55%,
69.30% and 83.11%, the acute monocytic leukemia cell line
THP-1, breast carcinoma MCF-7 and cervical carcinomaTable 2 Minimal Inhibitory Concentrations (MIC) results for a
dietary spices (μg/ml)
Microorganisms Extracts
FHF FHB GLB GLL
Bacteria
S. aureus - - 250 500
S. epidermitis - - 250 500
E. coli 500 - 500 -
P. aeruginosa 500 - 1000 -
MRSA - - 1000
VRE - - 1000
Fungi
C. albicans 500 - 500 250
C. krusei - - 1000 250
C. tropicalis - - 125 62.5
A. fumigatus 500 1000 1000 1000
FHF: Methanol extract from Fagara heitzii fruits; FHB: Methanol extract from Fagara
extract from Garcina lucida leaves; HLR: Methanol extract from Hymenocardia lyrata
extract from Hymenocardia lyrata barks; Cipro: Ciprofloxacin; Amph B: AmphothericHeLa) were more sensitive to the extracts than the two
others tumor cell lines tested (lung A549 adenocarcinoma,
prostate carcinoma PC-3). This observation indicated that
the extracts selectively inhibited the growth of different
tumor cells. To some extent, these results were similar to
those of previous studies that extracts from some spices
selectively inhibit the growth of human cancer cell
[10,12,13]. In contrast, all the extracts had low inhibitory
effects on the growth of A549 suggesting the resistance of
this cell line towards the tested samples.
All the extracts were initially screened at one concen-
tration (100 μg/ml); then dose-dependant inhibition was
further performed to determine IC50 (Table 1). Results
indicated that almost all plant extracts exerted cytotoxic
activity against at least one of the five cell lines usedntimicrobial activity of extracts from some Cameroonian
Antibiotics
HLR HLBa HLBb Cipro AmphB
62.5 500 125 0.25 nd
62.5 500 125 0.25 nd
- 1000 500 0.25 nd
- - 500 1 nd
125 500 125 6 nd
125 1000 125 64 nd
500 nd 500 nd 0.5
1000 nd 1000 nd 1
125 nd 125 nd 0.5
1000 nd 1000 nd 0.5
heitzii barks; GLB: Methanol extract from Garcina lucida barks; GLL: Methanol
roots; HLBa: Aqueous extract from Hymenocardia lyrata barks; HLBb: Methanol
in B; -: MIC>1000 μg/mL; nd: not determined.
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antiproliferative properties were observed with FHB and
the methanol extract from H. lyrata roots (HLR) with
IC50 of 8.4 μg/ml and 9.5 μg/ml against THP-1 and PC-
3 respectively. Interesting cytotoxic activity was also ob-
served against MCF-7 cell line, for the methanol extract
from F. heitzii fruits and barks (FHF and FHB respect-
ively) and the methanol extract from H. lyrata roots
(HLR) with IC50 of 26 μg/ml, 42 μg/ml and 32 μg/ml re-
spectively, while extract from Garcinia lucida barks and
leaves (GLB and GLL respectively) demonstrated weak
antiproliferative ability with IC50 of 73 μg/ml and 82 μg/
ml respectively. According to the criteria of the Ameri-
can National Cancer Institute the anticancer activity of a
crude extract promising for further purification based in
the IC50 values is lower than 30 μg/mL [14]. Considering
this criteria, IC50 values of FHF (IC50 of 26 μg/ml), FHB
(IC50. of 8.4 μg/ml) and HLR (IC50. of 9.5 μg/ml) re-
spectively on MCF-7, THP-1 and PC-3 are well within
the limit. Therefore, FHF, FHB and HLR could be consid-
ered as promising sources for new natural products with
cytotoxic properties. Extracts from F. lepreuiri, Fagara
macrophylla and Garcinia lucida (fruits) have earlier been
reported to contain potentially antiproliferative activity
[10]. These results are consistent with previous work that
has been carried out on dietary plants confirming their
ability to prevent cancer [2].
Results of the antimicrobial assay are depicted in
Table 2. All the extracts tested in this study exhibited
antimicrobial activities against bacteria and/or fungi.
The minimum inhibitory concentration (MIC) values
ranged from 62.5 μg/ml to 1000 μg/ml. HLR had the
highest antibacterial and antifungal activity against Gram-
positive bacteria S. aureus and S. epidermitis. According
to Kuete [15], the antimicrobial activity of extracts can be
classified as follows: significant if MIC values are below
100 μg/ml, moderate when 100<MIC<625 μg/ml and
weak if MIC>625 μg/ml. Therefore, the overall antibacter-
ial activity exhibited in this study varied from weak to
significant. Among the six bacterial strains tested, the two
Gram-positive bacteria (S. aureus and S. epidermitis) were
the most sensitive to the extracts, while the two Gram-
negative bacteria strains (E. coli and P. aeruginosa) were
the most resistant. These results were consistent with the
common observation that Gram-positive bacteria are ge-
nerally more sensitive to the spice and herb extracts than
Gram-negative bacteria. The resistance of Gram-negative
bacteria towards antibacterial substances is due to their
outer membrane that contributes to the intrinsic resist-
ance by acting as an efficient permeability barrier [16].
The antibacterial activity of other edible plants was previ-
ously reported by many authors [17,18]. It is noteworthy
that HLR showed moderate growth inhibiting activity
against MRSA and VRE which are two bacterial strainsexpressing MDR phenotypes. Probably the activity exerted
by these extracts is due to the presence of natural bio-
active compounds with either a new mode of action or
which are able to escape or to inhibit the mechanism of
resistance of these MDR bacteria. Previous study reported
the ability of some plant extracts to inhibit efflux pumps
resistance mechanism in bacteria [9,19]. The tested
extracts differed greatly in their activity against fungi and
the best inhibition was observed with GLL with MIC of
62.5 μg/ml against C. tropicalis. In a similar study, Hamza
et al. [20] reported that extracts having MIC of 0.5 mg/ml
or less as being strong inhibitors of fungal growth. Their
report was based on classification of MIC earlier proposed
by Aligiannis et al. [21] who classified plant extracts hav-
ing MIC of 0.5 mg/ml as strong inhibitors of fungal
growth; MIC between 0.6 and 1.5 mg/ml as moderated
inhibitors and extracts having MIC above 1.6 mg/ml con-
sidered as weak inhibitors.Taking in consideration this
classification, our extracts shown strong and moderate an-
tifungal activity.
Conclusions
It comes out from this study that the methanol extract
of H. lyrata roots significanly prevent the proliferation
of THP-1 and PC-3 cancer cell lines while the methanol
extract of F. heitzii barks inhibit the growth of Gram-
positive bacteria. These extracts could be potentially use-
ful for the development of therapeutic agents against
bacteria infections as well as for prostate and leukemia
cancer. In addition these results bring supporting data
that consumption of plants could reduce our susceptibil-
ity to some cancers. These extracts are good candidates
for further activity-guided fractionation in the search for
new active therapeutic compounds.
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